Intra-Cellular Therapies to Present at Two Upcoming Investor Conferences

Rhea-AI Summary

Intra-Cellular Therapies, a biopharmaceutical company focused on CNS disorders, announced that Dr. Sharon Mates, CEO and Chairman, will present at two investor conferences. The first is the Jefferies Virtual Healthcare Conference on June 2 at 11:30 am ET, followed by the Goldman Sachs 42nd Annual Global Healthcare Conference on June 10 at 1:20 pm ET. Live and archived webcasts will be available on the company’s website. Intra-Cellular leverages Nobel prize-winning research to develop treatments for complex psychiatric and neurologic diseases.

NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at two upcoming investor conferences:

Jefferies Virtual Healthcare Conference

Wednesday, June 2 at 11:30 am ET

Goldman Sachs 42^nd Annual Global Healthcare Conference

Thursday, June 10 at 1:20 pm ET

The live and archived webcasts can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases.

Contact:

Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D. 
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Lisa Burns
cradinovic@burnsmc.com
212-213-0006

Source: Intra-Cellular Therapies Inc.

FAQ

When is the Jefferies Virtual Healthcare Conference presentation by Intra-Cellular Therapies?

The Jefferies Virtual Healthcare Conference presentation is scheduled for June 2 at 11:30 am ET.

What date is the Goldman Sachs 42nd Annual Global Healthcare Conference for Intra-Cellular Therapies?

The Goldman Sachs 42nd Annual Global Healthcare Conference is on June 10 at 1:20 pm ET.

Where can I access the live webcast of Intra-Cellular Therapies' conferences?

The live and archived webcasts can be accessed in the 'Events & Presentations' section of Intra-Cellular Therapies' website.

Who is presenting at the upcoming investor conferences for Intra-Cellular Therapies?

Dr. Sharon Mates, CEO and Chairman, is scheduled to present at the upcoming investor conferences.

What is the focus of Intra-Cellular Therapies as a biopharmaceutical company?

Intra-Cellular Therapies focuses on developing therapeutics for central nervous system disorders.